About Akira Pharma Private Limited
Data last updated:
Akira Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 November 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51101DL2009PTC196057. Its GSTIN is 07AAICA3223E1Z5 (Delhi).
The company has an authorised share capital of ₹7 Cr and a paid-up capital of ₹24.05 Lakh. It is led by directors Gurpreet Sandhu Singh and Trilochan Singh Sandhu.
Its last annual general meeting (AGM) was held on 06 October 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 4 Ground Floor Part A Village Mahipalpur, Main Vasant Kunj Road Opp. Jagan Nath Complex, New Delhi, Delhi, India – 110037.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.66 Cr, a growth of 85% compared to the previous year. For the same year it recorded a net profit of ₹3.23 Cr (net margin 48.6%) and EBITDA of ₹5 Cr (EBITDA margin 75.2%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years and 82% over five years.
As per MCA filings, the company has open charges of ₹3 Cr on record. The company has 7 deals on record (5 secondary share transfers, 2 funding rounds), with disclosed funding of ₹5.79 Cr; the latest was in March 2023.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website revapharma.com.
Company details
Contact details
Akira Pharma Private Limited's registered office is in New Delhi, Delhi. Its website is revapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressA – 4 Ground Floor Part A Village Mahipalpur, Main Vasant Kunj Road Opp. Jagan Nath Complex, New Delhi, Delhi, India – 110037
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Akira Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Akira Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Akira Pharma Private Limited, buy the company report.
Financials of Akira Pharma Private Limited
FY 2025 filings availableAkira Pharma Private Limited reported revenue of ₹6.66 Cr (up 85% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 82% over five years, including 85% growth in the latest year. EBITDA rose 157% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.23 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 75.2% | ||||
| Net Profit Margin | 48.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Akira Pharma Private Limited, buy the company report.
Board of directors of Akira Pharma Private Limited
Akira Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gurpreet Sandhu Singh Also directs: Revapharma LLP, Reva Medicare Private Limited, Akira Developers Private Limited and 2 more | Director | 17 Nov 2009 | 16 Years 11 Months | Current |
| Trilochan Singh Sandhu Also directs: Akira Developers Private Limited | Director | 19 Aug 2013 | 13 Years 2 Months | Current |
Auditor
Akira Pharma Private Limited is audited by SHARMA SUDHIR & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHARMA SUDHIR & ASSOCIATES | FY 2020 | 033878N |
Shareholding
The shareholding of Akira Pharma Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Akira Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 14 Oct 2024 | 101022084 | Hdfc Bank Limited | ₹1.6 Cr | Open | |
| 23 Mar 2024 | 100958317 | Others | ₹1.4 Cr | Open |
Total charge records: 2 View all charges
Deals & funding
Akira Pharma Private Limited has 7 deals on record (5 secondary share transfers, 2 funding rounds), with disclosed funding of ₹5.79 Cr; the latest was in March 2023.
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2023 | Secondary share transfer | Undisclosed | Seller: Opax Invest Finance Corp, 3 individuals |
| Mar 2014 | Funding round | ₹23.1 Lakh | Investors: 2 individuals |
| Mar 2014 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
| Aug 2013 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 3 individuals |
| Mar 2012 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
To see the full deal history of Akira Pharma Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Akira Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Akira Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Akira Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAICA3223E1Z5 | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Akira Pharma Private Limited, buy the company report.
Recent activity
Akira Pharma Private Limited has 4 board changes on record since 2009: 2 appointments and 2 cessations. The latest: Harshit Singh ceased to be Company Secretary on 30 Nov 2019.
Frequently asked questions
Akira Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 November 2009 (17+ years old) and is registered under CIN U51101DL2009PTC196057.
Akira Pharma has 2 current directors:
- Gurpreet Sandhu Singh - Director
- Trilochan Singh Sandhu - Director
The latest financial statements of Akira Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 06 October 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Akira Pharma is 07AAICA3223E1Z5, registered in Delhi.
The CIN (Corporate Identification Number) of Akira Pharma is U51101DL2009PTC196057. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Akira Pharma was incorporated on 17 November 2009, making it 17+ years old. It is registered with the Registrar of Companies, Delhi.
Akira Pharma has 7 deals on record (5 secondary share transfers, 2 funding rounds), with disclosed funding of ₹5.79 Cr; the latest was in March 2023.
Harshit Singh ceased to be Company Secretary on 30 Nov 2019. Anuradha Sandhu ceased to be Director on 20 Aug 2013. Trilochan Singh Sandhu was appointed as Director on 19 Aug 2013. Akira Pharma has 4 board changes on record in total.
Akira Pharma can be reached through the website revapharma.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Akira Pharma is at A – 4 Ground Floor Part A Village Mahipalpur, Main Vasant Kunj Road Opp. Jagan Nath Complex, New Delhi, Delhi, India – 110037.